City
Epaper

Centre's COVID-19 vaccination plan ambitious but also realistic: Secy Dept of Science and Technology

By ANI | Updated: May 31, 2021 02:55 IST

The Centre's COVID-19 vaccination plan to innoculate all citizens of the country by December 31 is not only ambitious but also realistic, said Dr Ashutosh Sharma, Secretary, Department of Science and Technology.

Open in App

The Centre's COVID-19 vaccination plan to innoculate all citizens of the country by December 31 is not only ambitious but also realistic, said Dr Ashutosh Sharma, Secretary, Department of Science and Technology.

"In terms of technology, we are totally prepared for the third wave and would get even better as we go forward this year. Our vaccination plan to innoculate all citizens of the country by December is not only ambitious but also realistic," Dr Sharma toldon Sunday.

"During the first wave, we built a huge infrastructure which was related to basic things like ventilator, all kinds of diagnostics, PPE kits, N-95 masks, now we even have a vaccine which is of Indian origin. In addition to setting up the infrastructure for vaccine, cold chain, the supply lines, logistics, all have been put together quickly in the first wave," Dr Sharma said.

He added, "the second wave was rather sudden and we found that certain things were missing and that was not as much available in quantity as was needed at the peak of the second wave."

Speaking about the innovation related to oxygen supply, he said many innovations have been done related to the oxygen supply like repurposing many oxygen plants where plants that were producing industrial oxygen have been repurposed for the medical oxygen.

As India battles the second wave of the coronavirus pandemic science-based start-ups and innovations are playing a crucial role.

Speaking on innovation related to RT-PCR testing, the doctor said that new RT-PCR from Sree Chitra Tirunal Institute for Medical Sciences and Technology targets two genes, one of which does not undergo many mutations. "So, we will not produce false RT-PCR readings as much as otherwise might happen."

"An antibody kit has been developed at Indian Institute of Science, Bangalore. lt looks at antibodies IgM and IgG. The kit measures the quantity of antibodies. It also determines if they are fading." Dr Sharma added.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: indiabangaloreSree Chitra Tirunal Institute For Medical Sciences And TechnologyDepartment of science and technologyNodal departmentIndiUk-indiaScience and innovation blade nzimandeRepublic of indiaDepartment of science and technology of india
Open in App

Related Stories

OpinionsWhy is Trump So Upset with India?

MumbaiUniversity of Bristol Chooses Mumbai for Its First Overseas Campus, Set to Open in September 2026

NationalBengaluru: Three Women Followed and Chased by Men, Share Shocking Video

NationalRaksha Bandhan 2025: Now You Can Send a Rakhi to Your Brother in India Post's Waterproof Envelope — Here's How to Track Your Parcel

NationalGold in Dubai Cheaper Than India: Pricing, Rules, and Import Limits Explained

National Realted Stories

NationalComplaints filed against Adoor Gopalakrishnan over remarks on SC/ST filmmakers

NationalTejashwi himself made mistake in process: BJP, JD(U) slam RJD leader over 'name missing' from voter roll claim

NationalHaryana rights panel comes to rescue of senior citizen for denying basic entitlements

NationalDharmasthala mass grave probe: SIT nears end of excavation with final 3 sites today

NationalNet direct tax collection surges after reduction of corporate tax rates: Minister